Media & Resources

In this episode of Meet the Scientist, IAVI's podcast series, we explore the pivotal significance of community engagement in global collaborative research. Tune in to discover how IAVI is highlighting the importance of community partnership and engagement, an integral part of the product development process. Joyeeta Mukherjee, Ph.D., associate director of access, research, and development at IAVI in India, joins us to share insights into her work at the intersection of community and science. Join the conversation as we delve into the critical role of community engagement in global scientific pursuits. Plus, learn how innovative use of gamification and experiential learning is being used to simplify complex scientific concepts. Do not miss this fascinating exploration at the forefront of science and community collaboration! 

Progress & Passion Driving HIV Vaccine Research: NICD's Perspective In this episode, William Dekker, a Communication Specialist at IAVI, engages in a thoughtful conversation with Thandeka Moyo-Gwete, Ph.D., and Dale Kitchin, Ph.D., both distinguished senior scientists at the National Institute for Communicable Diseases (NICD) in South Africa. In recognition of HIV Vaccine Awareness Day (HVAD), this dialogue delves into the essential role of HIV vaccines and the continuous pursuit of research and development for a safe and effective vaccine against HIV. Both Thandeka and Dale offer insights into what fuels their dedication and the substantial efforts their team is making to propel the field of HIV vaccine research forward.

In Amsterdam, we sat down with Gabriela Gomez, senior director of global access at IAVI, to discuss her work using modeling to understand the potential impact of a new tuberculosis (TB) vaccine. As the COVID-19 pandemic has waned, TB once again has become the leading infectious cause of death in much of the world. In 2021, an estimated 1.6 million people died as a result of TB disease, making a new TB vaccine all the more vital. Gabriela Gomez also uses modeling to better understand how a new TB vaccine can be developed and distributed in an equitable and accessible way.This podcast will explore the importance of epidemiology—a branch of medical science that investigates all the factors that determine the presence or absence of diseases—in TB vaccine R&D and global health access in general. Listen to the first episode of our new series Meet The Scientist to learn more about how IAVI is using epidemiology to develop affordable, globally accessible vaccines and antibodies.

In this episode, KAVI-ICR scientists, Marianne Mureithi, Ph.D., Walter Jaoko, M.D., Ph.D., Daniel Muema, Ph.D., and Terry Muhomah, Ph.D. share their personal stories and shed light on what motivates them to do what they do. They provide insights into how they balance their personal lives with their scientific pursuits and discuss the significant contributions of women in science. They also reveal interesting highlights from their work and share their experiences of navigating the highs and lows of scientific research. Join us for an intimate conversation with the people behind the science and discover what inspires these scientists to tackle one of the greatest public health challenges of our time. Stay tuned to Impact Voices as we continue to showcase the people, science, and network driving HIV prevention research in Africa.

Welcome to the first episode of Impact Voices – a podcast on the people, the science, and the network driving HIV prevention research in Africa. Impact Voices podcast walks you through the journey to accelerate the development of vaccines and new technologies to combat the AIDS epidemic. In this episode, Marianne Mureithi, Ph.D., the basic sciences research team leader at the KAVI Institute of Clinical Research (KAVI-ICR) sat down with her colleagues at the institution, including Walter Jaoko, M.D., Ph.D., the director, and scientists Daniel Muema, Ph.D., and Terry Muhomah, Ph.D. Together, they share KAVI-ICR's journey and milestones, including their quest for a vaccine against HIV and the promise that comes with ongoing efforts to strengthen capacity for future scientists. Tune in to hear firsthand about the groundbreaking research being conducted at KAVI-ICR and the progress being made towards a vaccine against HIV and other public health challenges of our time.

In this episode of Inside IAVI, Finora Franck, senior specialist, laboratory operations, sat down with some of our longest-serving laboratory colleagues to give a glimpse inside our global labs, and to reflect on some of their most formative moments with IAVI. The work in the laboratories discussed in this podcast is made possible by the support of the American People through the United States Agency for International Development (USAID) and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). The content of this podcast is the sole responsibility of IAVI and does not necessarily reflect the views of USAID, PEPFAR, or the United States Government.

In conversation with Seth Berkley & Mark Feinberg: 25 years of innovation, partnerships, and access As we mark  25 years of IAVI,  we’re  inviting our current President and CEO, Mark Feinberg and IAVI’s former CEO Seth Berkley, who is now the CEO of Gavi, The Vaccine Alliance, to  reflect  on IAVI’s accomplishments  and the current global health landscape. In  this special edition of Inside IAVI,  Kristen Abboud, managing editor of IAVI Report, sat down with Mark and Seth  to reminisce on the last 25 years of IAVI, reflect on lessons learned as leaders in global health, and discuss what the future holds for IAVI and the global vaccine research and development landscape.

Inside IAVI is a podcast about the people  behind our mission.  Inside IAVI celebrates our mission to  translate scientific discoveries into affordable, globally accessible public health solutions. In  this  first episode  of Inside IAVI,  our  COO Ana Céspedes  is joined by four female colleagues and leaders at IAVI who have spent their careers advancing global health solutions. With tenures ranging from eight  to 20  years,  the panelists come together to discuss why diversity in  global health  leadership is important and some of their most  formative  moments  at IAVI.